Table 2.
References | Biomarker | Tissue | Baseline biomarker | Sample size (m/f) | AD | p * | |
---|---|---|---|---|---|---|---|
C/P | C | P | |||||
Jernigan and colleagues 34 | mTOR | PFC | 0.616 ± 0.055/0.42 ± 0.06 a | 10/2 | 10/2 | Yes/ser, flu, par, amit | 0.0017 |
Jernigan and colleagues 34 | P70S6K | PFC | 0.54 ± 0.046/0.37 ± 0.04 a | 10/2 | 10/2 | Yes/ser, flu, par, amit | 0.001 |
Jernigan and colleagues 34 | eIF4B | PFC | 0.78 ± 0.14/0.26 ± 0.10 a | 10/2 | 10/2 | Yes/ser, flu, par, amit | 0.0039 |
Jernigan and colleagues 34 | Phospho-eIF4B | PFC | 2.18 ± 0.36/1.18 ± 0.32 a | 10/2 | 10/2 | Yes/ser, flu, par, amit | 0.0004 |
Feyissa and colleagues 62 | PSD95 | PFC | 0.91 ± 0.15/0.54 ± 0.1 a | 11/3 | 11/3 | Yes/ser, flu, par, amit | <0.05 |
Karege and colleagues 63 | GSK-3β | PFC | 7.6 ± 2.3/11.6 ± 2.5 b | 5/5 | 5/5 | NR | 0.002 |
Karege and colleagues 63 | Akt | PFC | 27.3 ± 9.0/18.8 ± 5.1 b | 5/5 | 5/5 | NR | 0.002 |
Martins-de-Souza and colleagues 64 | Akt | Brain | NR | 8/4 | 13/11 | NR | 0.02 |
Ota and colleagues 22 | REDD1 | PFC | ~1/~1.7 c | NR | NR | NR | 0.012 |
Dwivedi and colleagues 65 | BDNF | PFC | 1.61 ± 0.39/0.94 ± 0.22 a | 17/4 | 11 | NR | <0.001 |
Dwivedi and colleagues 65 | BDNF | HIP | 1.71 ± 0.44/1.04 ± 0.20 a | 17/4 | 11 | NR | <0.001 |
Karege and colleagues 66 | BDNF | PFC | 17.5 ± 3.0/13.8 ± 2.6 d | 8 | 7 | DF | <0.002 |
Karege and colleagues 66 | BDNF | PFC | 17.5 ± 3.0/17.9 ± 2.9 d | 8 | 7 | Yes/NR | 0.36 NS |
Karege and colleagues 66 | BDNF | HIP | 24.5 ± 3.6/17.7 ± 2.9 d | 8 | 7 | DF | <0.002 |
Karege and colleagues 66 | BDNF | HIP | 24.5 ± 3.6/23.3 ± 2.2 d | 8 | 7 | Yes/NR | 0.36 NS |
Chen and colleagues 67 | BDNF | HIP | ~20/~35 e | 153 | 15 | Yes/NR | 0.09 NS |
Dwivedi and colleagues 65 | BDNF mRNA | PFC | 606.8 ± 139.5/352.2 ± 133.9 f | 17/4 | 11 | NR | <0.001 |
Dwivedi and colleagues 65 | BDNF mRNA | HIP | 2049.4 ± 642.8/1075.1 ± 200.6 f | 17/4 | 11 | NR | <0.001 |
C, healthy control; P, patient; m, male; f, female; DF, drug free; NR, not reported; NS, not significant; amit, amitriptyline; ser, sertraline; par, paroxetine; flu, fluoxetine. For all other abbreviations, see list of abbreviations.
Protein levels normalized to actin.
Kinase activity expressed in pmol/min/mg of brain tissue.
Fold change relative to control.
Amount of protein expressed in ng/g brain tissue.
Protein immunoreactivity.
mRNA level relative to neuron-specific enolase (NSE) mRNA.
All presented p values are statistically significant unless indicated otherwise.